Quality of Life of Ghanaian Chronic Myeloid Leukaemia Patients on Tyrosine Kinase Inhibitors

被引：0
|
作者：
Kuma, A. Benneh-Akwasi [1 ,2 ]
Amponsah, E. [3 ]
Kyeremeh, R. [3 ]
Olayemi, E. [1 ,2 ]
机构：
[1] Univ Ghana, Haematol, Accra, Ghana
[2] Korle Bu Teaching Hosp, Accra, Ghana
[3] Univ Ghana, Med Lab Sci, Accra, Ghana
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷
关键词：
Chronic myeloid leukaemia; Ghana; Quality of Life; Tyrosine Kinase Inhibitor;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH18-PO-0
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [21] Why chronic myeloid leukaemia cannot be cured by tyrosine kinase-inhibitors
    Michele Baccarani
    Robert Peter Gale
    Leukemia, 2021, 35 : 2199 - 2204
  • [22] Why chronic myeloid leukaemia cannot be cured by tyrosine kinase-inhibitors
    Baccarani, Michele
    Gale, Robert Peter
    LEUKEMIA, 2021, 35 (08) : 2199 - 2204
  • [23] EVALUATION OF THE PROTEASOMAL EFFECTS OF TYROSINE KINASE INHIBITORS AND BORTEZOMIB IN CHRONIC MYELOID LEUKAEMIA
    McCloskey, M.
    McMullin, M. F.
    Walker, B.
    Irvine, A. E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 125 - 125
  • [24] Impact of Low Grade Effects of Tyrosine Kinase Inhibitors on the Quality of Life of Patients Treated for Chronic Myeloid Leukemia
    Benlazar, Sidi Mohamed El Amine
    Hadjeb, Asma
    Zemri, Naima
    Ouadah, Fouzia
    Siali, Najet
    Zouaoui, Zahia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S286 - S286
  • [25] Optimizing health-related quality of life in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
    Efficace, Fabio
    Vignetti, Marco
    Sparano, Francesco
    Scalzulli, Emilia
    Breccia, Massimo
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (03) : 293 - 302
  • [26] Tyrosine kinase inhibitors impress in treatment of myeloid leukaemia
    Fricker, Janet
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (02) : 72 - 72
  • [27] The role of stem cell transplantation in paediatric patients with chronic myeloid leukaemia in the era of tyrosine kinase inhibitors
    Suttorp, M.
    Tauer, J. T.
    von Neuhoff, N.
    Nowasz, C.
    Bradtke, J.
    Teigler-Schlegel, A.
    Thiede, C.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S52 - S52
  • [28] CHRONIC MYELOID LEUKAEMIA (CML): EVALUATION OF EFFICACY OF THE TREATMENT WITH INHIBITORS OF TYROSINE KINASE (ITK) IN 31 PATIENTS
    Garcia Susana, Ramirez
    Jimenez Isabel, Vazquez-Pastor
    Juan Nicolas, Rodriguez Rodriguez
    Vallellano Antonio, Palma
    Esparraga Encarnacion, Gil
    Korrecha Karoll, Gomez
    Yasmina, Skiredj
    Bautista Rocio, Zapata
    Maria Antonia, Ruiz Cobos
    HAEMATOLOGICA, 2016, 101 : 351 - 351
  • [29] Side effects of treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukaemia and the occurrence of depressive symptoms
    Gibek, Katarzyna
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2023, 27 (04): : 277 - 283
  • [30] Financial toxicity and quality of life among people with chronic myeloid leukemia on tyrosine kinase inhibitors
    Burns, Emily J.
    Paul, Sudeshna
    Lee, Stephanie
    Jin, Ruiqi
    Henry, Rema
    Jennings, Bonnie Mowinski
    Waldrop, Drenna
    Hunter, Anthony
    Bruner, Deborah Watkins
    Yeager, Katherine
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345